US Stock MarketDetailed Quotes
NVNOW ENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM)
- 0.0063
- 0.00000.00%
Close May 30 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0063Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.023752wk High0.00P/B0Float Cap0.006052wk Low--Dividend TTM0Shs Float0.5500Historical High--Div YieldTTM0.00%Amplitude0.0060Historical Low--Avg Price1Lot Size
ENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -13.04%5.35M | -2.46%6.81M | 27.40%6.8M | 47.59%24.93M | -28.17%6.46M | 127.23%6.15M | 192.79%6.99M | 89.99%5.34M | 84.92%16.89M | 116.26%8.99M |
| Selling and administrative expenses | -30.28%2.55M | -33.55%2.6M | -15.36%3.2M | 34.51%15.02M | -49.20%3.66M | 146.90%3.66M | 201.93%3.91M | 221.68%3.78M | 128.66%11.17M | 283.33%7.21M |
| Research and development costs | 12.28%2.8M | 37.13%4.21M | 131.64%3.6M | 73.08%9.91M | 56.96%2.8M | 103.43%2.49M | 181.93%3.07M | -4.90%1.55M | 34.71%5.73M | -21.75%1.78M |
| Operating profit | 13.04%-5.35M | 2.46%-6.81M | -27.40%-6.8M | -47.59%-24.93M | 28.17%-6.46M | -127.23%-6.15M | -192.79%-6.99M | -89.99%-5.34M | -84.92%-16.89M | -116.26%-8.99M |
| Net non-operating interest income expense | -41.33%44K | 5.41%39K | 800.00%45K | 747.37%161K | 780.00%44K | 1,400.00%75K | 428.57%37K | 66.67%5K | 408.16%19K | 1,492.36%5K |
| Non-operating interest income | -41.33%44K | 5.41%39K | 800.00%45K | 747.37%161K | 780.00%44K | 1,400.00%75K | --37K | 66.67%5K | --19K | --5K |
| Other net income (expense) | 1,547.62%304K | 366.37%301K | 360K | -70.52%102K | 236K | -106.71%-21K | -11,400.00%-113K | 8,541.08%346K | 0 | |
| Gain on sale of security | 1,547.62%304K | 366.37%301K | --360K | --102K | --236K | ---21K | ---113K | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --313K | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---313K | --0 |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 115.28%33K | --0 |
| Income before tax | 17.98%-5M | 8.33%-6.47M | -19.92%-6.39M | -49.26%-24.67M | 31.24%-6.18M | -155.21%-6.1M | -196.97%-7.06M | -92.21%-5.33M | -80.92%-16.53M | -105.49%-8.99M |
| Income tax | ||||||||||
| Net income | 17.98%-5M | 8.33%-6.47M | -19.92%-6.39M | -49.26%-24.67M | 31.24%-6.18M | -155.21%-6.1M | -196.97%-7.06M | -92.21%-5.33M | -80.92%-16.53M | -105.49%-8.99M |
| Net income continuous Operations | 17.98%-5M | 8.33%-6.47M | -19.92%-6.39M | -49.26%-24.67M | 31.24%-6.18M | -155.21%-6.1M | -196.97%-7.06M | -92.21%-5.33M | -80.92%-16.53M | -105.49%-8.99M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 17.98%-5M | 8.33%-6.47M | -19.92%-6.39M | -49.26%-24.67M | 31.24%-6.18M | -155.21%-6.1M | -196.97%-7.06M | -92.21%-5.33M | -80.92%-16.53M | -105.49%-8.99M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 17.98%-5M | 8.33%-6.47M | -19.92%-6.39M | -49.26%-24.67M | 31.24%-6.18M | -155.21%-6.1M | -196.97%-7.06M | -92.21%-5.33M | -69.64%-16.53M | -81.31%-8.99M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data